Back to User profile » Dr James McGrory
Papers published by Dr James McGrory:
Treatment Patterns and Outcomes from OASIS: A Prospective Observational Study of Long-Acting Injectables in Schizophrenia
Weiden PJ, Strand LN, Doane MJ, Arevalo C, McGrory JA, Achtyes ED, Harvey PD, Kane JM, Saklad SR, Trotter J, Velligan DI
Neuropsychiatric Disease and Treatment 2025, 21:2165-2181
Published Date: 23 September 2025
Aripiprazole Lauroxil Every 2 Months or Paliperidone Palmitate Monthly for Acute Schizophrenia: A Post Hoc Analysis of PANSS Five-Factor Scores in the ALPINE Trial
Citrome L, Dunbar M, McGrory JA
Neuropsychiatric Disease and Treatment 2025, 21:1047-1055
Published Date: 14 May 2025
Aripiprazole Lauroxil: Development and Evidence-Based Review of a Long-Acting Injectable Atypical Antipsychotic for the Treatment of Schizophrenia
Citrome L, Correll CU, Cutler AJ, Dunbar M, Hoberg AR, Hopkinson C, Mattingly GW, McGrory JA, Rege B, Weiden PJ, McDonnell D
Neuropsychiatric Disease and Treatment 2025, 21:575-596
Published Date: 14 March 2025
Changes in Clinical Management of Patients with Schizophrenia Treated with Long-Acting Injectable Antipsychotics (LAIs), Including Telepsychiatry Use, During the COVID-19 Pandemic
Haider B, O'Sullivan AK, Bessonova L, Keane E, Achtyes E, Harvey PD, Kane JM, Saklad SR, Trotter JP, Claxton A, Polak T, McGrory J, Noori W, Sikora Kessler A, Yarlas A, Velligan D
Neuropsychiatric Disease and Treatment 2023, 19:623-634
Published Date: 17 March 2023